Literature DB >> 10581982

Clozapine, neuroleptic malignant syndrome, and pancerebellar syndrome.

T M Brown1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10581982     DOI: 10.1016/S0033-3182(99)71192-8

Source DB:  PubMed          Journal:  Psychosomatics        ISSN: 0033-3182            Impact factor:   2.386


× No keyword cloud information.
  5 in total

Review 1.  Children with schizophrenia: clinical picture and pharmacological treatment.

Authors:  Gabriele Masi; Maria Mucci; Cinzia Pari
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

Review 2.  Benefit-risk assessment of atypical antipsychotics in the treatment of schizophrenia and comorbid disorders in children and adolescents.

Authors:  Paz Toren; Sharon Ratner; Nathaniel Laor; Abraham Weizman
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

3.  A rare case of neuroleptic malignant syndrome presenting with serious hyperthermia treated with a non-invasive cooling device: a case report.

Authors:  Christian Storm; Rolf Gebker; Anne Krüger; Lutz Nibbe; Joerg C Schefold; Frank Martens; Dietrich Hasper
Journal:  J Med Case Rep       Date:  2009-02-19

4.  Paediatric atypical antipsychotic monitoring safety (PAMS) study: pilot study in children and adolescents in secondary- and tertiary-care settings.

Authors:  Fariz A Rani; Patrick J Byrne; Macey L Murray; Paul Carter; Ian C K Wong
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

Review 5.  The neurological and cognitive consequences of hyperthermia.

Authors:  Edward James Walter; Mike Carraretto
Journal:  Crit Care       Date:  2016-07-14       Impact factor: 9.097

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.